Icecure Medical Ltd (ICCM)

08:30 AM

IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - Stock Titan

08:30 AM

Apr 26, 2025

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems - marketscreener.com

Apr 26, 2025

Apr 22, 2025

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - StreetInsider

Apr 22, 2025

Apr 22, 2025

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation | ICCM Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Clinical Trial Reveals Revolutionary Breast Cancer Treatment: ProSense Shows 94% Success, Zero Complications - Stock Titan

Apr 22, 2025

Apr 22, 2025

IceCure Medical (NASDAQ:ICCM) Shares Down 3.1% – Time to Sell? - Defense World

Apr 22, 2025

Apr 10, 2025

IceCure Medical Announces Special Shareholder Meeting for May 2025 - TipRanks

Apr 10, 2025

Mar 31, 2025

FY2027 EPS Estimates for IceCure Medical Reduced by Analyst - Defense World

Mar 31, 2025

Mar 30, 2025

IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright - Defense World

Mar 30, 2025

Mar 28, 2025

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results - Zacks Investment Research

Mar 28, 2025

Mar 28, 2025

Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer - Targeted Oncology

Mar 28, 2025

Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target By Investing.com - Investing.com India

Mar 28, 2025

Mar 28, 2025

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 28, 2025

Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target - Investing.com

Mar 28, 2025

Mar 28, 2025

IceCure Medical Reports Growth and Awaits FDA Decision - TipRanks

Mar 28, 2025

Mar 27, 2025

IceCure Medical Ltd’s Earnings Call: Growth Amidst Challenges - TipRanks

Mar 27, 2025

Mar 27, 2025

IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 - PR Newswire

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses - Investing.com

Mar 27, 2025

Mar 27, 2025

IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America - StreetInsider.com

Mar 27, 2025

Mar 26, 2025

Earnings Outlook For Icecure Medical - Benzinga

Mar 26, 2025

Mar 25, 2025

IceCure Medical aims to bring cold cancer treatment to Vietnam - Mugglehead Magazine

Mar 25, 2025

Mar 25, 2025

IceCure Medical (ICCM) Projected to Post Earnings on Thursday - Defense World

Mar 25, 2025

Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate - The Malaysian Reserve

Mar 24, 2025

Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Res - GuruFocus

Mar 24, 2025

Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study - Investing.com India

Mar 24, 2025

Mar 20, 2025

IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer - The Malaysian Reserve

Mar 20, 2025

Mar 20, 2025

Targeting ESR1 Mutations in Breast Cancer With Novel Therapies - Targeted Oncology

Mar 20, 2025

Mar 20, 2025

IceCure stock tumbles after update on ProSense (ICCM:NASDAQ) - Seeking Alpha

Mar 20, 2025

Mar 20, 2025

IceCure Medical Ltd. Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense®? Cryoablation in Early-Stage Breast Cancer - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

IceCure Medical Expects FDA Decision on ProSense After Q1 -March 20, 2025 at 09:20 am EDT - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment - Investing.com

Mar 20, 2025

Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment By Investing.com - Investing.com UK

Mar 20, 2025

Mar 18, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference - PR Newswire

Mar 18, 2025

Mar 18, 2025

Critical Survey: IceCure Medical (NASDAQ:ICCM) and Medifocus (OTCMKTS:MDFZF) - Defense World

Mar 18, 2025

Mar 17, 2025

IceCure secures patent for cryogenic pump in China By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology - Quantisnow

Mar 17, 2025

Mar 17, 2025

IceCure Gets Notice of Allowance from China's Intellectual Property Regulator -March 17, 2025 at 09:07 am EDT - MarketScreener

Mar 17, 2025

Mar 17, 2025

IceCure secures patent for cryogenic pump in China - Investing.com

Mar 17, 2025

Mar 17, 2025

Market Sentiment Around Loss-Making IceCure Medical Ltd (NASDAQ:ICCM) - Simply Wall St

Mar 17, 2025

Mar 15, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Present - GuruFocus.com

Mar 15, 2025